• Dabigatran Etexilate: Redefining Oral Anticoagulation and Dr

  2026-07-16

  Dabigatran etexilate introduces a direct thrombin inhibition strategy that circumvents CYP3A-mediated metabolism, addressing longstanding limitations in anticoagulation therapy such as variable pharmacokinetics and frequent drug-drug interactions. This innovation has significant implications for the design of cardiovascular drug interaction and pharmacokinetic studies.

• Peripheral Macrophages Drive Pain Priming in Chronic Hypoxia

  2026-07-16

  This study identifies peripheral macrophage recruitment as a key driver of nociceptor sensitization and persistent pain in a mouse model of chronic intermittent hypoxia, recapitulating features of obstructive sleep apnea (OSA). The findings offer mechanistic insight into immune-mediated pain in OSA and highlight new targets for therapeutic intervention.

• Helper-Polymer FNPs Enable Stable, Lung-Targeted mRNA Delive

  2026-07-15

  The reference study introduces five-element nanoparticles (FNPs) formulated with poly(β-amino esters) and DOTAP, achieving highly stable, lung-specific mRNA delivery after lyophilization. This innovation addresses key challenges in mRNA therapeutic storage and extrahepatic targeting, with significant implications for pulmonary disease treatment and vaccine distribution.

• Sodium Nitroprusside: Applied Workflows for Vascular Researc

  2026-07-15

  Sodium Nitroprusside, a potent nitric oxide donor, enables high-precision modeling of vascular smooth muscle relaxation and platelet aggregation inhibition. This article delivers stepwise protocols and troubleshooting insights, translating recent sex-difference hypertension findings into actionable research strategies.

• Cholesterol Impedes Endosomal Trafficking of Lipid Nanoparti

  2026-07-14

  This study reveals that elevated cholesterol content in lipid nanoparticles (LNPs) leads to their aggregation in peripheral endosomes, impairing intracellular trafficking and reducing nucleic acid delivery efficiency. The findings highlight the importance of cholesterol optimization in LNP formulations for improved cargo delivery.

• Recombinant Human IL-15 (E.coli): Potency, Mechanism, and Pr

  2026-07-14

  Recombinant Human IL-15 (E.coli, Tag Free, Lyophilized) is a potent cytokine for T and NK cell activation, supporting robust immune modulation in research assays. This article details its molecular features, validated activity, and integration into immunological workflows, referencing APExBIO's proven product and recent neuroimmune studies.

• Red Blood Cell Membrane Bending Rigidity: Insights from Spec

  2026-07-13

  The reference study delineates the intrinsic bending rigidity of the red blood cell cytoplasmic membrane (RBCcm) by removing the confounding spectrin network, revealing a notably low bending modulus. This finding challenges previous literature and has implications for understanding RBC deformability, blood flow dynamics, and experimental approaches in membrane biophysics.

• Advancing Hazardous Bioaerosol Detection: Eliminating Pollen

  2026-07-13

  Zhang et al. (2024) developed a robust workflow combining excitation–emission matrix fluorescence spectroscopy and advanced spectral transformations to identify and remove pollen interference in hazardous bioaerosol classification. Their approach notably increased classification accuracy, enabling more reliable detection of harmful substances for public health applications.

• Isoprinosine in Immunotherapy: Workflows and Herpesvirus Egr

  2026-07-12

  Isoprinosine (inosine pranobex) is redefining antiviral immunomodulation with its dual-action profile—direct viral inhibition and immune enhancement. This article unpacks advanced workflows, troubleshooting strategies, and the translational significance of recent mechanistic breakthroughs, enabling researchers to maximize outcomes in viral infection models.

• Annexin V-FITC/PI Apoptosis Assay Kit: Technical Application

  2026-07-10

  The Annexin V-FITC/PI Apoptosis Assay Kit enables rapid, fluorescence-based discrimination between viable, early apoptotic, and late apoptotic or necrotic cells. It is specifically designed for research applications requiring precise assessment of cell death pathways by flow cytometry or microscopy. This kit is not suitable for diagnostic or clinical use and should not be used outside the scope of laboratory research.

• Technical Use of HyperScribe™ T7 High Yield Cy3 RNA Labeling

  2026-07-09

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus addresses the need for reproducible, high-yield fluorescent RNA probe synthesis for sensitive research applications such as in situ hybridization and Northern blotting. It is not intended for diagnostic or therapeutic purposes and should be applied strictly within research workflows requiring Cy3-labeled RNA.

• Qimai Feiluoping Decoction Targets PI3K/AKT/mTOR in Pulmonar

  2026-07-09

  This study demonstrates that Qimai Feiluoping decoction (QM) alleviates pulmonary fibrosis by inhibiting the PI3K/AKT/mTOR pathway and restoring autophagy, particularly by suppressing endothelial mesenchymal transition (EndMT). The results provide mechanistic insight into antifibrotic strategies and highlight the translational potential of targeting mTOR signaling in interstitial lung disease models.

• Patient-Derived 3D Spheroid Models for Organ-Confined Prosta

  2026-07-08

  This study establishes a robust method to generate and characterize three-dimensional spheroid cultures from radical prostatectomy specimens as a translational model for organ-confined prostate cancer. The findings highlight the utility and limitations of patient-derived 3D cultures for drug testing and mechanistic studies, providing a valuable resource for preclinical research.

• BFH772 (VEGFR2 inhibitor): Technical Guidance for Angiogenes

  2026-07-08

  BFH772 (VEGFR2 inhibitor) is a highly selective small molecule optimized for studies requiring precise inhibition of the VEGFR2 signaling pathway, such as tumor angiogenesis research. It should be avoided in workflows demanding water solubility or broad-spectrum kinase inhibition.

• Angiotensin 1/2 (5-7): Precision Modulation in RAS and Viral

  2026-07-07

  Explore the multifaceted role of Angiotensin 1/2 (5-7) in blood pressure regulation and its emerging significance in SARS-CoV-2 spike protein interactions. This article offers in-depth, protocol-driven insight beyond existing summaries, equipping researchers with a nuanced understanding of this pivotal H2N-Ile-His-Pro-OH peptide.

11801 records 1/787 page Next 12345 下5页 Last page